About 10 µg of unmodified and acro-apoE3 were electrophoresed by SDS-PAGE using a 4-12% Bis-Tris NuPAGE gel in MOPS buffer (Invitrogen, Carlsbad, CA). The bands corresponding to 36 (and 72 kDa for acro-apoE3) were excised and subjected to in-gel digestion with trypsin or elastase, the former using a robot (ProGest, DigiLab); the gel pieces were washed
with 25 mM ammonium bicarbonate and acetonitrile, reduced with 10 mM dithiothreitol at 60 ºC, alkylated with 50 mM iodoacetamide at 24 ºC, and digested with either trypsin or elastase (Promega Corporation, Madison, WI) for 4 h at 37 ºC at a 20:1 ratio (protein/protease, w/w).
The digestion was quenched with formic acid and the supernatant analyzed directly (without further processing) by nano LC-MS/MS with a Waters NanoAcquity HPLC system interfaced to a ThermoFisher Q Exactive. The digested peptides were loaded on a trapping column and eluted over a 75 µm analytical column at 350 nl/min; both columns were packed with Luna C18 resin 
Co-IP assay
The LDLr binding ability of apoE3/rHDL and acro-apoE3/rHDL was determined by a co-IP assay. A soluble construct bearing the essential LDLr ligand binding domains LA3-LA6 with a c-myc epitope (referred to as sLDLr) was used (2). ApoE3/rHDL or acro-apoE3/rHDL (10 µg) was incubated with 10 µg of sLDLr in the presence of 2 mM CaCl2 in PBS for 1 h at 4 °C. This 
